Correlation Between Crispr Therapeutics and Moderna
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Moderna, you can compare the effects of market volatilities on Crispr Therapeutics and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Moderna.
Diversification Opportunities for Crispr Therapeutics and Moderna
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crispr and Moderna is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Moderna go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Moderna
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 0.98 times more return on investment than Moderna. However, Crispr Therapeutics AG is 1.02 times less risky than Moderna. It trades about 0.03 of its potential returns per unit of risk. Moderna is currently generating about -0.37 per unit of risk. If you would invest 4,600 in Crispr Therapeutics AG on August 24, 2024 and sell it today you would earn a total of 29.00 from holding Crispr Therapeutics AG or generate 0.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Moderna
Performance |
| Timeline |
| Crispr Therapeutics |
| Moderna |
Crispr Therapeutics and Moderna Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Moderna
The main advantage of trading using opposite Crispr Therapeutics and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Moderna vs. ZyVersa Therapeutics | Moderna vs. Sonnet Biotherapeutics Holdings | Moderna vs. Zura Bio Limited | Moderna vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |